Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital (Q37290815)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2008

Language	Label	Description	Also known as
English	Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital	scientific article published on June 2008

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital (English)

1 reference

Europe PubMed Central

19 August 2017

Helicobacter pylori

0 references

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Siok-Siong Ching

1

1 reference

Europe PubMed Central

19 August 2017

Sivakumaran Sabanathan

2

1 reference

Europe PubMed Central

19 August 2017

Lloyd-R Jenkinson

3

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

19 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

19 August 2017

14

1 reference

Europe PubMed Central

19 August 2017

24

1 reference

Europe PubMed Central

19 August 2017

3855-3860

1 reference

Europe PubMed Central

19 August 2017

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

6 September 2017

Helicobacter pylori diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

6 September 2017

Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

6 September 2017

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

6 September 2017

Quadruple therapy for symptomatic spontaneous duodenal ulcer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

6 September 2017

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

26 June 2018

Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Effectiveness of triple therapy and quadruple therapy for Helicobacter pylori eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patien

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

3 September 2018

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2721442

20 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of Helicobacter pylori therapies in a clinical practice setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso

1 reference

https://pubmed.ncbi.nlm.nih.gov/18609709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.14.3855

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37290815&oldid=2141100818"